-+ 0.00%
-+ 0.00%
-+ 0.00%

AMNEAL ANNOUNCES EXPANDED COVERAGE FOR CREXONT® (CARBIDOPA AND LEVODOPA) TO ENHANCE ACCESS FOR PARKINSON’S DISEASE PATIENTS IN THE U.S.

Reuters·04/03/2025 12:03:40

Please log in to view news